Microsoft Research unveiled BioEmu, a generative deep learning system capable of rapidly emulating protein equilibrium ensembles with high accuracy, accelerating protein dynamics research beyond traditional molecular dynamics simulations. Parallel efforts at Monash University utilized AI to design proteins that inhibit membrane transporters in antibiotic-resistant bacteria. These breakthroughs illustrate AI’s expanding role in drug design and molecular biology, promising more efficient therapeutic development.